Allspring Global Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
AC
SCM
Allspring Global Investments's IRWD Position: Q2 2026 in Review
Allspring Global Investments increased its Ironwood Pharmaceuticals (IRWD) stake by 3.9% in Q2 2026, buying an estimated $12K and bringing the position to 82,315 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1548.
Allspring Global Investments first reported a position in IRWD in Q4 2021 and has held it in 16 quarters since. The position peaked at $11.9M in Q1 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.
- Allspring Global Investments held 82,315 shares of Ironwood Pharmaceuticals worth $339K as of Q2 2026.
- Allspring Global Investments bought 3,122 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $12K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1548 holding.
- Allspring Global Investments first reported a position in Ironwood Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
- Allspring Global Investments's Ironwood Pharmaceuticals position peaked at $11.9M in Q1 2022.
- 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.